Cardiff Oncology, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cardiff Oncology, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2023.
  • Cardiff Oncology, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $183K, a 1.67% increase year-over-year.
  • Cardiff Oncology, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $730K, a 1.96% increase year-over-year.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2023 was $737K, a 20.4% increase from 2022.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2022 was $612K, a 35.5% decline from 2021.
  • Cardiff Oncology, Inc. annual Operating Lease, Payments for 2021 was $949K, a 0.53% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $730K $183K +$3K +1.67% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $727K $185K +$115K +164% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $612K $182K -$41K -18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $653K $180K -$63K -25.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $716K $180K -$63K -25.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $779K $70K -$170K -70.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $949K $223K -$15K -6.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $964K $243K +$6K +2.53% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $958K $243K +$7K +2.97% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $951K $240K +$7K +3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $944K $238K +$7.1K +3.08% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $937K $237K +$7.07K +3.08% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $930K $236K +$6.43K +2.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $923K $233K +$6.64K +2.93% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $917K $231K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $230K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $230K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $226K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.